Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Colorcon
Cerilliant
Julphar
Merck
Fuji
AstraZeneca
US Army
Novartis
McKinsey

Generated: January 23, 2018

DrugPatentWatch Database Preview

HECTOROL Drug Profile

« Back to Dashboard

When do Hectorol patents expire, and when can generic versions of Hectorol launch?

Hectorol is a drug marketed by Genzyme Corp and is included in two NDAs.

The generic ingredient in HECTOROL is doxercalciferol. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the doxercalciferol profile page.
Drug patent expirations by year for HECTOROL
Pharmacology for HECTOROL
Ingredient-typeErgocalciferols
Drug ClassVitamin D2 Analog

US Patents and Regulatory Information for HECTOROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-002 Apr 23, 2004 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-002 Apr 6, 2000 AP RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-003 Jul 13, 2009 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-001 Apr 6, 2000 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HECTOROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-001 Apr 6, 2000 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-002 Apr 23, 2004 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-001 Apr 6, 2000 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-002 Apr 23, 2004 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-003 Jul 13, 2009 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol CAPSULE;ORAL 020862-001 Jun 9, 1999 ➤ Subscribe ➤ Subscribe
Genzyme Corp HECTOROL doxercalciferol INJECTABLE;INJECTION 021027-002 Apr 6, 2000 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for HECTOROL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Injection 2 mcg/mL, 1 mL in 2 mL vial ➤ Subscribe 12/28/2011
➤ Subscribe Capsules 1 mcg ➤ Subscribe 2/12/2010
➤ Subscribe Capsules 0.5 mcg and 2.5 mcg ➤ Subscribe 3/25/2009
➤ Subscribe Injection 2 mcg/mL, 2 mL ampules ➤ Subscribe 10/15/2007

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Harvard Business School
Fuji
Healthtrust
Cantor Fitzgerald
Boehringer Ingelheim
Federal Trade Commission
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot